Algis Budrys (January 9, 1931 – June 9, 2008) was a Lithuanian-American science fiction author, editor, and critic. He was also known under the pen names "Frank Mason", "Alger Rome", "John A. Sentry", "William Scarff", "Paul Janvier", and "Sam & Janet Argo". Budrys was born Algirdas Jonas Budrys in Königsberg in East Prussia. He was the son of the consul general of the Lithuanian government (the pre-World War II government still recognized after the war by the United States, even though the Soviet-sponsored government was in power throughout most of Budrys's life). His family was sent to the United States by the Lithuanian government in 1936 when Budrys was 5 years old. During most of his adult life, he held a captain's commission in the Free Lithuanian Army. Budrys was educated at the University of Miami, and later at Columbia University in New York. His first published science fiction story was "The High Purpose", which appeared in Astounding Science Fiction in 1952. Beginning in 1952 Budrys worked as editor and manager for such science fiction publishers as Gnome Press and Galaxy Science Fiction. Some of his science fiction in the 1950s was published under the pen name "John A. Sentry", a reconfigured Anglification of his Lithuanian name. Among his other pseudonyms in the SF magazines of the 1950s and elsewhere, several revived as bylines for vignettes in his magazine Tomorrow Speculative Fiction, is "William Scarff". He also used the pen name "Alger Rome" in his collaborations with Jerome Bixby. Budrys's 1960 novella Rogue Moon was nominated for a Hugo Award, and was later anthologized in The Science Fiction Hall of Fame, Volume Two (1973). His Cold War science fiction novel Who? was adapted for the screen in 1973. In addition to numerous Hugo Award and Nebula Award nominations, Budrys won the Science Fiction Research Association's 2007 Pilgrim Award for lifetime contributions to speculative fiction scholarship. Budrys was married with 4 sons and last resided in Evanston, Illinois. He died at home, from metastatic malignant melanoma on June 9, 2008.[1]